Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Campbell

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|February 19, 2021
Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel DiseaseStamatia Papoutsopoulou, Barry J Campbell
Trends in Molecular Medicine|February 14, 2002
Inflammation and colorectal cancer: IBD-associated and sporadic cancer comparedJonathan M Rhodes, Barry J Campbell
World Journal of Gastroenterology|August 2, 2014
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel diseaseAhmed Tawfik, Paul K Flanagan, Barry J Campbell
Biochemical Society Transactions|July 27, 2011
Bacteria in the pathogenesis of inflammatory bowel diseasePaul Flanagan, Barry J Campbell, Jonathan M Rhodes
British Medical Bulletin|October 22, 2008
Host-bacteria interaction in inflammatory bowel diseasePaul Knight, Barry J Campbell, Jonathan M Rhodes
Chemical Society Reviews|August 19, 2010
RNA interference: a chemist's perspectiveJames W Gaynor, Barry J Campbell, Richard Cosstick
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapyYvette Merga, Barry J Campbell, Jonathan M Rhodes
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Lessons from diversion studies and antibacterial interventionsPaul K Flanagan, Barry J Campbell, Jonathan M Rhodes
Digestive Diseases (Basel, Switzerland)|December 23, 2014
IBD: microbiota manipulation through diet and modified bacteriaHannah L Simpson, Barry J Campbell, Jonathan M Rhodes
Biochemical Society Transactions|November 22, 2008
Lectin-epithelial interactions in the human colonJonathan M Rhodes, Barry J Campbell, Lu-Gang Yu
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|February 19, 2021
Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel DiseaseStamatia Papoutsopoulou, Barry J Campbell
Trends in Molecular Medicine|February 14, 2002
Inflammation and colorectal cancer: IBD-associated and sporadic cancer comparedJonathan M Rhodes, Barry J Campbell
World Journal of Gastroenterology|August 2, 2014
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel diseaseAhmed Tawfik, Paul K Flanagan, Barry J Campbell
Biochemical Society Transactions|July 27, 2011
Bacteria in the pathogenesis of inflammatory bowel diseasePaul Flanagan, Barry J Campbell, Jonathan M Rhodes
British Medical Bulletin|October 22, 2008
Host-bacteria interaction in inflammatory bowel diseasePaul Knight, Barry J Campbell, Jonathan M Rhodes
Chemical Society Reviews|August 19, 2010
RNA interference: a chemist's perspectiveJames W Gaynor, Barry J Campbell, Richard Cosstick
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapyYvette Merga, Barry J Campbell, Jonathan M Rhodes
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Lessons from diversion studies and antibacterial interventionsPaul K Flanagan, Barry J Campbell, Jonathan M Rhodes
Digestive Diseases (Basel, Switzerland)|December 23, 2014
IBD: microbiota manipulation through diet and modified bacteriaHannah L Simpson, Barry J Campbell, Jonathan M Rhodes
Biochemical Society Transactions|November 22, 2008
Lectin-epithelial interactions in the human colonJonathan M Rhodes, Barry J Campbell, Lu-Gang Yu
Pageof 6